siRNA Versus miRNA as Therapeutics for Gene Silencing - Wikidata - wikimedia - TriplyDB

siRNA Versus miRNA as Therapeutics for Gene Silencing

siRNA Versus miRNA as Therapeutics for Gene Silencing

http://www.wikidata.org/entity/Q26786876

about

Gene, Stem Cell, and Alternative Therapies for SCA 1 Tamoxifen Resistance: Emerging Molecular Targets Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside Network science for the identification of novel therapeutic targets in epilepsy Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical Applications Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis Plant MicroRNAs-Novel Players in Natural Medicine?Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer.Emerging Roles of circRNA Related to the Mechanical Stress in Human Cartilage Degradation of Osteoarthritis Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.The notorious R.N.A. in the spotlight - drug or target for the treatment of disease miRnalyze: an interactive database linking tool to unlock intuitive microRNA regulation of cell signaling pathways.Protoplast transformation as a potential platform for exploring gene function in Verticillium dahliae Circular RNA Related to the Chondrocyte ECM Regulates MMP13 Expression by Functioning as a MiR-136 'Sponge' in Human Cartilage Degradation.An Amphiphilic Peptide Induces Apoptosis Through the miR29b-p53 Pathway in Cancer Cells MicroRNA miR-204 and miR-1236 inhibit hepatitis B virus replication via two different mechanisms.Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.Hairpin Ribozyme Genes Curtail Alcohol Drinking: from Rational Design to in vivo Effects in the Rat MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells Gold Nanoparticle Approach to the Selective Delivery of Gene Silencing in Cancer-The Case for Combined Delivery?Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases.Inflammation-induced miRNA-155 inhibits self-renewal of neural stem cells via suppression of CCAAT/enhancer binding protein β (C/EBPβ) expression.Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection.Photocrosslinkable, biodegradable hydrogels with controlled cell adhesivity for prolonged siRNA delivery to hMSCs to enhance their osteogenic differentiation.Small Players Ruling the Hard Game: siRNA in Bone Regeneration.RNAi Screening of the Glucose-Regulated Chaperones in Cancer with Self-Assembled siRNA Nanostructures.Changing calcium: CRAC channel (STIM and Orai) expression, splicing, and posttranslational modifiers.DNA methyltransferase inhibitors: an updated patent review (2012-2015).Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Immunomodulatory Nanomedicine.MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?Inhibitors of connexin and pannexin channels as potential therapeutics.Applying Fluorescence Resonance Energy Transfer (FRET) to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing.New tumor suppressor microRNAs target glypican-3 in human liver cancer.RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations.Microscale Symmetrical Electroporator Array as a Versatile Molecular Delivery System Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing

P2860

Q26738497-80CC0CFA-C863-4D79-B17A-864CCAE1CDA5 Q26739969-0513752D-EF7A-469D-9C0A-5ADAD8F48BC6 Q26741449-C2518D8F-1E0C-4222-BCB0-8030796E6751 Q26745355-F37D7C95-DB0A-43E3-BB07-A231D0954461 Q26752417-4198F864-C5B6-4FBD-9BAA-BA0178ECE064 Q26768588-8D5AEDD1-8C73-40BE-8B4F-63AB025037FA Q28066239-9125B733-2CB5-4BF4-8D80-6B1426F9397A Q28067306-067831D8-FD10-411A-836A-630F790EF310 Q30368082-FC7EC99E-1141-40B6-AB5F-967039D2BA70 Q33633097-D90700E7-AD8F-45DA-8D4C-A16DDCDED85D Q33720978-CD722E45-7A32-4F0D-86BD-51F7AE57F65F Q33738954-F2BB013F-B2C9-4304-889B-6CB01561EF55 Q33739733-AF707048-8A6C-45F9-88AC-09743AE02016 Q33787523-A7398634-215A-47F6-BF95-3339008C4A59 Q36085103-27DE29E0-D3E6-4D90-B609-00027D102AE5 Q36638569-3643D9D6-1D10-4A3C-8305-F32382554FE1 Q37238932-B3CD835E-DFC2-468B-9EC0-39DE024935B5 Q37335521-344AFD57-6032-4927-8BBF-ECB5DAED3F70 Q37636279-DB7EF2C8-4580-466E-8BC5-7AC9A124013A Q37672325-36DFA9C5-D3A9-4D84-A17A-B021E009C500 Q37706967-B5F68AE5-1ED9-44F5-A013-B168A5F0C1DC Q37708924-D42F2815-A2E7-4884-9E3D-424FD6EBE581 Q37724113-DB8A30B7-710B-4732-B7EA-327D118CD4E3 Q37724407-D9088CC5-7176-40C2-9D2B-6E0AF2EA434B Q37736251-377DB60B-C2CD-46F1-A2FB-DFB4E2C597E7 Q37741183-1605508C-E971-4B96-86CA-4586C4785558 Q38707859-C1F773AA-B8D2-4BA3-A97B-EACE656C40C8 Q38738927-DA678831-E9A8-42CF-B761-57E2D21B3A34 Q38743723-4636EC6B-50DB-4928-AA33-7DFFF569F27A Q38748679-A4D05304-CA1B-4B4E-B3A2-67EDD7153A7D Q38885370-AD2DB4D2-7100-4652-9447-DA240BAAAA79 Q39038930-81B5292D-7525-4380-85C3-FE7FB269725F Q39224331-6B0911DE-804E-4264-9206-41EE41A20A3C Q39324079-12566207-AE16-42C8-9780-C5B2FDF16396 Q39442549-24F3534E-2DBC-4114-9270-2A834239AC6F Q40093677-0BABD5B2-9F4E-4611-A522-5ADACCDD1C36 Q41093562-5AD16BCA-6980-4504-BEF1-66D4DBEF8111 Q42048496-8B497899-AB7F-4DEE-A31C-A961005F84B3 Q42315390-8C82CFCF-3A34-4D1B-A22C-08ABEA57C778 Q42324545-E8CC82EE-2360-4BF3-A110-DF241782389E

P2860

siRNA Versus miRNA as Therapeutics for Gene Silencing

http://www.wikidata.org/entity/Q26786876

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

siRNA Versus miRNA as Therapeutics for Gene Silencing

@ast

siRNA Versus miRNA as Therapeutics for Gene Silencing

@en

siRNA Versus miRNA as Therapeutics for Gene Silencing

@nl

type

label

siRNA Versus miRNA as Therapeutics for Gene Silencing

@ast

siRNA Versus miRNA as Therapeutics for Gene Silencing

@en

siRNA Versus miRNA as Therapeutics for Gene Silencing

@nl

prefLabel

siRNA Versus miRNA as Therapeutics for Gene Silencing

@ast

siRNA Versus miRNA as Therapeutics for Gene Silencing

@en

siRNA Versus miRNA as Therapeutics for Gene Silencing

@nl

P1433

Q26786876-775B4029-00CE-44FA-B81D-45D5E3222DD1

P1476

Q26786876-73CB84EE-054D-4FC3-867C-D89EDF07D80B

P2093

Q26786876-06C0CC42-F4C6-4710-9F3E-5AFA29F0D7ED

Q26786876-0C10CF70-76AB-4A21-B170-BCDAF3938D6D

Q26786876-BA15FD1E-3E5E-4940-8E78-E483D8CA0D13

P2860

Q26786876-014BAB2F-E043-4396-A689-CD05B3E01DC4

Q26786876-01863561-BFAE-4393-AAB3-6EF326157AA2

Q26786876-0275EDDD-EEC3-463E-BEA3-21C5E7CC64F6

Q26786876-02A321D4-2B1C-4DBA-A892-AACF7BFEEAFF

Q26786876-03621F85-40B5-4B36-9BEA-56F8833421F1

Q26786876-04E41468-FB16-4600-921C-A6E3B4E9B562

Q26786876-0614564D-5E41-4A56-A959-B6D49665F8EE

Q26786876-09933B0D-8134-4CE6-A4CD-DA8A460A9803

Q26786876-0A6CC02E-D139-4A7B-B874-56FDD9BDB57D

Q26786876-0A95E6E3-8F38-4181-8091-D408408C586D

P304

Q26786876-80A57CEF-7112-4446-95BE-938E166CF04F

P31

Q26786876-931400CD-8388-4BDE-88B2-7D4999FD50DD

P3181

Q26786876-9DC353F5-C16B-415E-B7D2-CF5192C1D270

P356

Q26786876-3B6E3CC8-B01E-48AA-BE6E-B5861AA1C1C5

P407

Q26786876-EBAA5054-D3B7-4C21-9FB2-67E91557F304

P433

Q26786876-F12EDBA7-DCBA-4EE7-B914-9A793D17EE36

P478

Q26786876-0A91A5CE-00BB-4823-BB53-F8B138CA5D30

P50

Q26786876-096526E4-FC5A-4F4D-B0A1-DCA2E81B9F36

P577

Q26786876-169A8BB8-0EE5-40BB-B8B4-BED117632965

P5875

Q26786876-A210D40A-D5C8-4D20-948C-41D04220C60F

P698

Q26786876-D1833E55-A0F2-407E-80CB-937866A24EC8

P921

Q26786876-13F9227C-7C71-46E0-8AF3-5A7FF0A24AE8

P932

Q26786876-510ED5DD-CC32-4A21-9524-F8B6FFCA834E

P3181

P356

P1433

Molecular therapy. Nucleic acids

P1476

siRNA Versus miRNA as Therapeutics for Gene Silencing

@en

P2093

Michael Y T Chow

http://www.w3.org/2001/XMLSchema#string

Susan W S Leung

http://www.w3.org/2001/XMLSchema#string

Yu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.

RNA interference: biology, mechanism, and applications

MicroRNAs: target recognition and regulatory functions

miRBase: integrating microRNA annotation and deep-sequencing data

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

Suppression of non-small cell lung tumor development by the let-7 microRNA family

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

P304

e252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1612445

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/MTNA.2015.23

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282035687

http://www.w3.org/2001/XMLSchema#string

P698

26372022

http://www.w3.org/2001/XMLSchema#string

P921

P932

4877448

http://www.w3.org/2001/XMLSchema#string